Tuesday, January 06, 2015 9:36:01 AM
https://www.linkedin.com/profile/view?id=8873956&authType=NAME_SEARCH&authToken=H5c7&locale=en_US&trk=tyah&trkInfo=tarId%3A1420555028744%2Ctas%3Adaniel%20harpell%2Cidx%3A1-1-1
https://www.linkedin.com/profile/view?id=4772658&authType=NAME_SEARCH&authToken=GPwS&locale=en_US&srchid=68456891420555000108&srchindex=3&srchtotal=481&trk=vsrp_people_res_name&trkInfo=VSRPsearchId%3A68456891420555000108%2CVSRPtargetId%3A4772658%2CVSRPcmpt%3Aprimary
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM